NEUMORA THERAPEUTICS INC
NMRANASDAQ🏆 #3981 by market capEarnings Nov 5US Equity
$0.68▼ $0.01 (−2.10%)
Market closed · at closeTrack NMRA
Get earnings, price moves & breaking news on Telegram
24h▼ 2.1%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$126M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
68
Fair
NEUMORA THERAPEUTICS INC
NMRAAnalyst Ratings
Price
$0.6774
Total
9
Raised
1
Lowered
2
Avg PT
$4.50
H / L
$5 / $4
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
RBC Capital | Reiterated | Outperform | 2026-07-13 | $5.00 | +638.10% |
Mizuho | Reiterated | Outperform | 2026-06-18 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2026-06-16 | — | — |
Needham | Reiterated | Buy | 2026-06-16 | $8.00 | +1081.00% |
Guggenheim | Reiterated | Buy | 2026-03-31 | — | — |
William Blair | Upgraded | Market Perform → Outperform | 2026-02-17 | — | — |
Stifel | Reiterated | Hold | 2025-11-17 | — | — |
JP Morgan | Downgraded | Neutral → Underweight | 2025-09-16 | — | — |
B of A Securities | Downgraded | Buy → Underperform | 2025-04-02 | — | — |
Institution
RBC Capital
Reiterated · Outperform · 2026-07-13
$5.00
+638.10%
Mizuho
Reiterated · Outperform · 2026-06-18
—
—
HC Wainwright & Co.
Reiterated · Buy · 2026-06-16
—
—
Needham
Reiterated · Buy · 2026-06-16
$8.00
+1081.00%
Guggenheim
Reiterated · Buy · 2026-03-31
—
—
William Blair
Upgraded · Market Perform → Outperform · 2026-02-17
—
—
Stifel
Reiterated · Hold · 2025-11-17
—
—
JP Morgan
Downgraded · Neutral → Underweight · 2025-09-16
—
—
B of A Securities
Downgraded · Buy → Underperform · 2025-04-02
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space